Pathology and Cytology

Certainty starts with classification

Cell and tissue changes are rarely unambiguous.
Only their precise classification reveals what they signify and what the consequences are.

Pathology, cytology and molecular pathology provide the basis for this classification.
Transparent. Clinically relevant.

When reports require clarity

A report alone is not enough. What matters is how the findings should be understood.

Morphology, molecular analyses and the clinical context are condensed into a reliable statement. This does not serve as an isolated conclusion, but rather as the basis for the next decision to be made.

Diagnostics from a single source

Pathology, cytology, molecular pathology and genetics are all intertwined. Together, they create an unbroken line from the cellular and genetic changes through to the therapeutic implications.

Clear responsibility. Coordinated interpretation. A reliable basis for decision-making.

Quality is reflected in the classification

A diagnosis is made by means of professional comparison:

Structured second opinions in defined scenarios
Ongoing case discussions
Interdisciplinary coordination on complex findings

Interpretations are reviewed and accounted for.
This reduces uncertainty before a decision is made.

Molecular pathology – when mechanisms play a deciding role

Morphology describes structure.
Molecular analyses explain mechanisms.

Genetic changes clarify classifications and reveal treatment options.

This provides the report with the direction it needs.

Frozen section diagnostics – guidance during surgery

Intraoperative decisions cannot be postponed.

Frozen section diagnostics and Mohs surgery allow for an immediate assessment of the resection margins during the procedure. The surgeon receives reliable guidance in real time and treatment steps can be adapted immediately.

These procedures are available at the Allschwil, Epalinges, Geneva and Zurich locations as well as in numerous hospitals and medical practices.

Time becomes a matter of responsibility.

Tumour boards – decision-making in context

With tumour boards, reports are jointly evaluated and placed within a clinical context.

Combined, pathology, molecular pathology and clinical information allow a coordinated decision to be made.

Treatment plans are the result of interaction.

Report time – where time becomes clinically useful

For many indications, the time taken until the report is received affects what happens next.

Biopsies and extragenital cytology:
as a rule, reports are issued the following working day
Resectates:
reports are issued after two working days

Short report times provide a basis for quick, sustainable decisions to be made.

Dysplasia screening – prevention with consistency

Cervical cancer is largely preventable through consistent screening.

The key lies in diagnostic methods that identify relevant changes and monitor them closely.

Modern cytology combined with molecular diagnostics enables:

A cytological report within 48 hours
HPV and STI test results from the same sample
History of previous PAP and HPV findings
Systematic reminders for outstanding checks

Early detection works when it is implemented consistently.

Personal contact persons

Diagnostic classification is built on a process of exchange.

Viollier’s team of consultants supports attending physicians from histological and cytological assessment through to molecular pathological classification.

Direct. Interdisciplinary. Responsible. View the contact persons